Monthly Archives: August 2013

Biothera Advances Biomarker Research for Drug Candidate Imprime PGG

Biothera Advances Biomarker Research for Drug Candidate Imprime PGG

EAGAN, MN – August 23, 2013 – Biothera has identified a potential method for increasing the efficacy of its oncology drug candidate Imprime PGG®, an immunomodulator, in biomarker-negative patients. The results are the subject of a poster presentation this week at the International Congress on Immunology in Milan, Italy. Research Abstract. Previous research has identified a predictive biomarker for Imprime PGG, a soluble yeast beta...

Read More